Aurora Spine received U.S. Food and Drug Administration 510(k) clearance for the ZIP 51, the company's slimmest minimally invasive interspinous fixation implant for spinal fusion.
The ZIP 51 was developed as an alternative to pedicle screw fixation and designed for stabilization and load sharing during the TI-S1 thoracolumbar fusion procedures. It is also intended to be an adjunct to interbody fusion specifically for the treatment of degenerative disc disease spondylolisthesis trauma and/or tumor.
"Aurora is changing spine surgery and we are thrilled to receive FDA clearance with the ZIP 51 another key product in the Aurora Spine MIS Fusion System" said Trent J. Northcutt, president and CEO of Aurora Spine. "The new ZIP 51 represents our 5th FDA clearance in 11 months and maintains our position at the forefront introducing advanced innovative minimally disruptive spine surgery technologies."
More articles on devices:
Will Integra LifeScience's new spine products be enough to sustain growth before SeaSpine spin-off?
How will Medtronic pay for Covidien? $10B in bonds, for starters
Zimmer extends deadline for Biomet purchase review — 5 quick facts